HALOG (halcinonide cream) by PharmaIN is corticosteroid hormone receptor agonists [moa]. First approved in 1974.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
HALOG (halcinonide cream) is a topical corticosteroid that works by agonizing corticosteroid hormone receptors to reduce inflammation and immune response. It is indicated for inflammatory and pruritic manifestations of corticosteroid-responsive dermatological conditions. This small-molecule cream has been a dermatology staple since 1974.
HALOG faces significant competitive pressure (30/100) in a mature topical steroid market with limited growth trajectory, suggesting smaller brand teams and defensive positioning.
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Worked on HALOG at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on HALOG offers limited career growth due to its LOE-approaching status and lack of linked job openings; roles are primarily defensive commercial positions focused on market retention rather than expansion. This assignment suits professionals seeking stable, lower-visibility portfolio experience or those transitioning between growth-stage products.